BlackRock, Inc. 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 2:03 pm Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
14,658,349 16.600% |
302,250 (+2.11%) |
Filing |
| 2023-01-23 3:52 pm Sale |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
14,356,099 17.700% |
-328,688 (-2.24%) |
Filing |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
14,684,787 18.400% |
0 (Unchanged) |
Filing |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
14,684,787 18.400% |
2,182,867 (+17.46%) |
Filing |
| 2021-01-25 4:49 pm Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
12,501,920 16.600% |
-250,199 (-1.96%) |
Filing |